Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease.

Alessandra Saraga, Tina Deyhim, Ajay Gade, Grace Geeganage, Mostafa Soliman, Nathan David Vanshelboym Rothschild, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Adam S Cheifetz, Konstantinos Papamichael